Moreover, in contrast to HDs, our analyses show that TIGIT and PVRIG are significantly co-expressed on CD56dimCD16+ cells in AML, whereas CD39 is mainly found on CD56brightCD16− NK cells, which also co-express CD38 or TIGIT. Here, PVRIG is linked to acute myeloid leukemia.